Web Analytics

3 Latest Announced Rounds

  • $6,200,000
    Seed

    4 Investors

    Software Development
    Oct 8th, 2025
  • $8,129,205
    Unknown

    2 Investors

    Robotics Engineering
    Oct 8th, 2025
  • $24,000,000
    Series A

    2 Investors

    Hospital & Health Care
    Oct 8th, 2025
$762.17M Raised in 42 Funding Rounds in the past 7 Days - View All

Funding Round Profile

EnPlusOne Biosciences

start up
United States - Watertown, Massachusetts
  • 21/02/2025
  • Unknown
  • $10,000,000

EnPlusOne is on a mission to bring RNA and RNA solutions to the world. Its ezRNA™ synthesis platform is a stepwise innovation that can incorporate a diverse array of nucleotide modifications and promises a manufacturing process that can sustainably deliver therapeutic RNA at commercial scales. In addition to direct RNA synthesis, EnPlusOne's ezRNA™ platform supports a vast array of RNA solution applications. For more information, please visit www.enplusonebio.com


Related People

Daniel AhlstedtCo Founder

Daniel Ahlstedt United States - Boston, Massachusetts

Experienced biotechnology process engineer with a demonstrated history of supporting manufacturing operations, equipment design, and start-up of large capital projects while adhering to FDA and international regulations.